Remove Definition Remove FDA Remove Regulatory Compliance
article thumbnail

Channeling the Power of Generative Health AI: Implications for Health Care, Research, and Governance (Part II)

Bill of Health

No AI developer can definitively tell medical professionals what their model can achieve in specific health care contexts. Equally important is ensuring compliance with emerging legal frameworks such as the EU AI Act , FDA regulations, and other jurisdiction-specific requirements that govern AI in health care.

article thumbnail

FDA Guidance Shows a Regulatory Path Forward for Interoperable Devices

Exeed Regulatory Compliance

Market for interconnected medical devices is projected to grow but the regulatory pathway is still evolving. A new FDA guidance offers helpful recommendations for design and premarket submission. One way to understand how FDA is thinking about regulating these devices is to review recently cleared devices.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Steps to Consider When Dealing With 483 FDA and Warning Letters

Dot Compliance

The FDA sends an FDA Form 483 Observation, also known as a “inspectional observation” or “Form 483” to draw attention to any potential legal infractions discovered during a routine inspection. These are issued after a 483 FDA inspection. Without FDA notification, companies may get this paper in the mail.

FDA 52
article thumbnail

FDA Guidance for Face Shields and Respirators During the Covid-19 Pandemic

Exeed Regulatory Compliance

The FDA is consistently updating its Guidance and policy for various Face Masks, Face Shields and Respirators as new information becomes available. We recently discussed the FDA’s policy for Face Masks during COVID-19. So, there are two parts to the definition of these devices – what they are and how they are used.

article thumbnail

ONC’s HTI-1 Places Undue Burdens on Healthcare Providers, Health IT Developers

Healthcare IT Today

DSI and Predictive Models ONC is clearly attempting to leverage its certification program to help the Food and Drug Administration (FDA) increase transparency related to decision alerts, but this seems to be an inefficient and burdensome application of the certification lever.

FDA 97
article thumbnail

Navigating FDA’s New Guidance on Medical Device Servicing

HIT Consultant

Food & Drug Administrations (FDA) latest guidance issued in May 2024. The FDA issued this guidance to assist service organizations in distinguishing between service activities and remanufacturing activities. laws and regulations, the FDA leveled the playing field with this new guidance. Why the New Guidance?

FDA 52
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

While each company successfully gained FDA approvals, the current market acceptance for prescription digital therapeutics is low and improvements will take years. They will continue to run clinical trials to confirm their claims and value proposition but will not seek FDA approvals.